🔎Around 1 in 4 people with CCA have chronic liver diseases, and 1 in 10 have cirrhosis. Read more here: ❇️ ow.ly/GIh450X2qc0

📣This systematic review/meta-analysis yielded a coherent picture from a compositional perspective, which may help identify beneficial donor profiles and guide personalized FMT approaches. Read more here: ➡️ ow.ly/Tecs50X1uvA

This model quantifies the benefits of CT for at-risk FDRs of newly identified individuals with CRC and LS ➡️Read more: ow.ly/b7c950WZ7uk

These findings directly inform design of regulatory clinical trials with respect to managing concomitant medications at baseline ➡️ Read more: ow.ly/xsH650WVlVv

👩‍⚕️ Introducing #CGH Associate Editor, Dr. Lisa Strate! The most rewarding aspects of her role include: 1️⃣ collaborating with editors, authors, and reviewers 2️⃣ staying connected to cutting-edge science Read her bio here: ow.ly/6Lnp50WW1c5

📖 Non-invasive tests (NITs) for portal hypertension in PBC perform poorly in severe cholestasis. RESIST criteria outperform elastography-based tests for ruling out high-risk varices. Further studies needed to assess the performance of NITs in PBC-cACLD ▶️ ow.ly/JnMJ50WPRJS

Prognostic Communication, Symptom Burden, Psychological Distress, and Quality of Life Among Patients With Decompensated #Cirrhosis ➡️ ow.ly/WeMa50WPRuC

New study by @Yujun__Wong: Alcohol cirrhosis had lower risk of mortality after acute variceal bleeding. Cirrhosis etiology (ALD vs non-ALD) should be included in risk-stratification of AVB. Check out why bilirubin matters in this case. 🔗 ow.ly/AjJF50WPR1h

⭐ Worsening Disease Severity as Measured by I-SEE Associates With Decreased Treatment Response to Topical Steroids in Eosinophilic Esophagitis Patients: ow.ly/PWjv50WNLgu

Hypercoagulation After Hospital Discharge in Acute Severe Ulcerative #Colitis: A Prospective Study ➡️ ow.ly/gtXq50WLFlW

📖 #ICYMI, our September issue is live! This issue includes a review focusing on "Burden of Nonmalignant Liver and Pancreatic Diseases in the United States Population" ☑️ Read the full journal issue here: ow.ly/68oO50WLAUm

⭐ August Images and Videos presents: An Elusive #Pancreatic Mass 🔗 Learn more here: ow.ly/snjb50WHxUN

A Real-World Study of Cumulative Steroid Burden Among Patients With Eosinophilic #Esophagitis in the United States ➡️ ow.ly/UcsK50WHxHQ

Environmental Risk Factors for Gallbladder Cancer: Field-Wide Systematic Review and Meta-Analysis ➡️ ow.ly/1bQ350WHxju

⭐Practice Management: The Road Ahead article examines impact of artificial intelligence on the #gastroenterology workforce and practice Learn more here ➡️ ow.ly/wtAg50WByRc

📖 These results demonstrate that the Atmo Capsule is a valid method for evaluating gastrointestinal transit: ow.ly/yztt50WByHv

This study suggests that a diet with high TAC may help prevent the development of #IBD, particularly in individuals at high genetic risk of IBD and in mutation carriers of rs4880 in SOD2 ➡️ ow.ly/wyTk50WByvO

📖 Anti-integrin αvβ6 Autoantibodies Are Increased in Primary Sclerosing Cholangitis Patients With Concomitant Inflammatory Bowel Disease and Correlate With Liver Disease Severity 🔗 ow.ly/12aA50WyPU2

Histologic remission of MASH or significant fibrosis improves survival after bariatric surgery ➡️ ow.ly/r58N50WyPJe

A CGH #liver disease article was recently featured in the @latimes.com ▶️ ow.ly/mJa850WxGkJ 🔗 Don't miss the CGH piece here: ow.ly/4N0x50WxGkI @amergastroassn.bsky.social

Neighborhood-level SDOH are associated with MASLD burden, comorbidities, and mortality and should be considered in clinical care, quality improvement, and further research: ow.ly/VPSt50WyPA4

📖 Validation and Epidemiologic Definition of the Novel Steatotic #Liver Disease Nomenclature in a National United States Cohort With #Cirrhosis: ow.ly/5btu50Ww7Rh

⭐ ESG is an effective and safe method to promote weight reduction associated with significant improvement in patients with MASH and obesity. 🔗 Learn more: ow.ly/cUp750Ww7GK

1 year of gluten free diet improves but doesn’t reverse the impact of celiac disease on whole gut transit time and small bowel water content; reduces Bifidobacteria, increases proteolytic species and reduces starch and arabinoxylan degrading families ➡️ ow.ly/hQQ550Ww7ia

Editor's Essential Reading ➡️ A review of the diagnosis and management of hemochrojmatosis, a genetic iron overload disease that is under diagnosed and treatable Learn more: ow.ly/NIl350WuZoz

📖 The August issue of CGH is live! 📖 Check it out here if you haven't already: ow.ly/6IJ950Wul89

Noninvasive Hepatic Steatosis and #Fibrosis Indices Differentially Predict Mortality in the Adult Korean Population ➡️ ow.ly/gx9550WsWNE

📖 Acute Severe Ulcerative #Colitis: An International Delphi Consensus on Clinical Trial Design and Endpoints 🔗 Read more at: ow.ly/cBGq50WpcXO

Intestinal Ultrasound Findings and Their Prognostic Value in Early Crohn’s Disease: A Copenhagen IBD Cohort Study ➡️ Learn more here: ow.ly/xg4X50WpcKQ

Older age but not comorbidity burden is associated with worse survival, including among patients with early-stage #HCC. Further studies are needed to define the role of comorbidity in HCC prognostication ➡️ ow.ly/9No050WpcBn

Older patients and those with elevated alpha-fetoprotein levels or poorer liver function are at greatest risk of #HCC, highlighting an unmet need for better risk stratification models ➡️ ow.ly/uCYZ50WlTof

Global Epidemiology and Characteristics of Metabolic Dysfunction-associated Steatotic Liver Disease in Type 1 Diabetes Mellitus: An Updated Systematic Review and Meta-analysis ➡️ ow.ly/jkm850WlTfc

Study examines the impact and interactions of race and gender on healthcare use and spending in #IBS ➡️ Learn more: ow.ly/73Iy50WjSHb

📢 CGH is thrilled to welcome its new editorial fellows Dr. Sunny Chung and Dr. Mai Sedki. 📰 See the AGA editorial fellows selected for our sister journals: gastro.org/news/meet-ou... @josephhabibimd.bsky.social @univmiami.bsky.social ‪ @yaleschoolofmed.bsky.social

A significant rise in MASH-associated liver cancer over the past two decades, with incidence rates increasing in over half of countries worldwide. Urgent action is needed to slow this trend. 🔗 ow.ly/AX5M50WjSog

Endoscopic Sedation Type During FLIP Panometry Does Not Significantly Impact FLIP Motility Classification Relative to Manometry ➡️ ow.ly/vZZH50WhOKN

📖 July Editor's Essential Reading presents: Point-of-Care Ultrasound in #Gastroenterology and #Hepatology 🔗 ow.ly/poXQ50WfJcx

🌟 Our July issue is out! It features an Essential Reading on point-of-care ultrasound in #gastroenterology and #hepatology, and more. Read the full issue here ➡️ ow.ly/G0HU50WfIBY

📖 Article examines: Health Care and Prescription Medication Affordability for #IBD in the United States in 2023 🔗 Read more below: ow.ly/2KE450W4nPj

CGH has received a 2024 Impact Factor of 12.0! Thank you to our editors, authors, reviewers, and readers for your continued support. gastro.org/news/aga-jou... #GastroSky #GISky #LiverSky

📢 #ICYMI, this article examines: The Role of #Endoscopy Skills Assessment Tools in Programmatic Assessment 💡 Learn more at www.cghjournal.org/article/S154...

Outpatient Intensive Nutrition Therapy Improves Survival and Frailty in Males With Alcohol-related ACLF - Randomized Controlled Trial ▶️ ow.ly/h04c50W4nsY

A Predictive Model Based on Quantitative Fecal Immunochemical Test Can Stratify the Risk of Colorectal Cancer in an Organized Screening Program ➡️ ow.ly/HIks50W4nn4

⭐ Two-sample FIT could effectively identify high-risk populations, and colonoscopy compliance is associated with a lower risk of CRC incidence and mortality. This strategy might facilitate CRC screening practice in countries with large populations: ow.ly/gJU150W4neL

📖 Epidemiology of Elderly Onset IBD: A Nationwide Population-Based Cohort Study 📖 Read the article here: ow.ly/ZFVc50W4mUx

📖 Global Prevalence of Advanced Liver ##Fibrosis and #Cirrhosis in the General Population: A Systematic Review and Meta-analysis: ow.ly/PLhC50W4msV

A diagnostic algorithm combining LSM and CAP within indeterminate VCTE identifies significant fibrosis and re-classifies patients into low-risk and high-risk AGA categories. The therapeutic window for MASLD opens with a CAP>280 dB/m + LSM>10.3 kPa ▶️ ow.ly/82U250W1VQl

⭐Patients with intestinal methanogen overgrowth #IMO exhibit several GI symptoms, including higher rates and severity of constipation and lower rates of diarrhea compared to controls, indicating a distinct GI symptom profile 📖 ow.ly/9YXh50W19gm #microbiome

🌟 Our June issue is live! You can read it here, including a new Educator and Trainee Perspectives article on: The Role of #Endoscopy Skills Assessment Tools in Programmatic Assessment 🔗 Full issue: ow.ly/J8rI50W18Tb

📖Switching EoE patients from off-label swallowed topical corticosteroids to budesonide orodispersible tablets is effective in achieving deeper histological remission, greater treatment satisfaction, better symptom control and quality of life. Learn more: ow.ly/IIKp50VXjZH